Blog

/Blog
Blog2018-03-04T18:00:55+00:00
602, 2018

Injectable Biologic Formulation Development

By |February 6th, 2018|Categories: Manufacturing, Research & Development|Tags: , , , , |0 Comments

The field has advanced considerably in recent years, but a number of key challenges remain. by Raymond E Peck, CEO of VxP Biologics Because injectable biologics are introduced directly into the body’s tissues, these formulations must be extraordinarily free from contamination of every kind. This requirement sets a high bar [...]

202, 2018

Sterile Biologics Manufacturing

By |February 2nd, 2018|Categories: Manufacturing|Tags: , |0 Comments

The correct choice of sterilized packaging is crucial, as is regulatory compliance. by Raymond E Peck, CEO of VxP Biologics While the potency and efficacy of active pharmaceutical ingredients (APIs) remain crucial in biologics manufacturing, the packaging of those drugs is equally critical in ensuring safety and stability. A wide [...]

2310, 2017

Flow Cytometry

By |October 23rd, 2017|Categories: Manufacturing, Research & Development|Tags: , , , |0 Comments

This powerful technique enables rapid identification and sorting of cells, streamlining the manufacture of many biologic pharmaceuticals. by Raymond E Peck, CEO of VxP Biologics In the manufacture of many types of biologics, flow cytometry is a crucial tool for identifying, analyzing and sorting cells. This technique can provide a [...]

1210, 2017

The Vero Vaccine Production Pipeline

By |October 12th, 2017|Categories: Research & Development|Tags: , , , |0 Comments

The Vero platform’s upstream and downstream processing stages are designed for maximum efficiency and safety, as well as purity of the final product. Despite many recent advances in vaccine development technology, the actual process of bringing new vaccines to the clinical trial stage often remains cumbersome and slow. Even the most elaborate recombinant technologies and vector systems may not integrate smoothly into an existing manufacturing pipeline, and inefficiencies and safety issues may emerge at any step of the process.

510, 2017

Advanced Development and Manufacturing of Antibody Technologies (ADAMANT)

By |October 5th, 2017|Categories: Research & Development|Tags: , , , , , |0 Comments

To help accelerate MCM development, VxP Biologics has developed its Advanced Development and Manufacturing of Antibody Technologies (ADAMANT) platform. This platform integrates cell libraries, region design and selection techniques, and formulation standards into a high-throughput production format. By optimizing and standardizing antibody design and production, ADAMANT helps biologic developers bring new antibody candidates to the clinical trial stage more rapidly.

110, 2017

Vero Cell Platform Technology

By |October 1st, 2017|Categories: Research & Development|Tags: , , , , |0 Comments

This cell development platform has proven effective in the creation of a number of viral vaccines. by Susan Thompson, Technical Director at VxP Biologics Recent years have witnessed a significant amount of innovation in technologies for the development of novel vaccines. These technologies include new vector systems for delivering attenuated [...]